Abstract: The present disclosure generally relates to improving programming to data storage devices, such as solid state drives (SSDs). A first memory device has a first XOR element and a second memory device has a second XOR element. The ratio of the first XOR element to the capacity of the first memory device is substantially smaller than the ratio of the second XOR element to the capacity of the second memory device. A read verify operation to find program failures is executed on either a wordline to wordline basis, an erase block to erase block basis, or both a wordline to wordline basis and an erase block to erase block basis. Because the program failures are found and fixed prior to programming to the second memory device, the second XOR element may be decreased substantially.

Abstract: A method and system for training and applying at least two neural networks for matching prospective students to institutions is disclosed This method and system enhances access to high-quality, affordable postsecondary education by predicting the likelihood of success that a given student will have at an institution. This is accomplished by predicting the similarity between a student and institution alumni on both objective and subjective criteria.

Abstract: This invention relates to a pre-portioned single, multiple, or fractional serving(s) in effervescent tablet form, containing doses of stimulants, amino acids, vitamins, and minerals in unique quantities to enhance performance of exercise related activities. The composition and delivery of these components is unique and solves problems pertaining to the traditional packaging, composition, and delivery methods used for these products. This invention provides a product that can serve as a pre-workout stimulant, energy aid, or exercise related improvement supplement that is delivered in effervescent tablet form.

Abstract: The present invention relates to compositions useful in inhibiting Bcl-XL or MCL-1 and disrupting p53-MDM2 and p53-MDMX interactions, and methods of using those compositions for treating a subject for conditions responsive to increasing p53 mediated activity or promoting p53 independent apoptosis, such as treating cancer. In some aspects, the compositions of this invention relate to fusion polypeptides comprising a human serum polypeptide and a p53-peptide, which can be, in some aspects, a p53 derived peptide and/or a p53 activating peptide.

Abstract: The present invention relates to compositions useful in inhibiting Bcl-XL or MCL-1 and disrupting p53-MDM2 and p53-MDMX interactions, and methods of using those compositions for treating a subject for conditions responsive to increasing p53 mediated activity or promoting p53 independent apoptosis, such as treating cancer. In some aspects, the compositions of this invention relate to fusion polypeptides comprising a human serum polypeptide and a p53-peptide, which can be, in some aspects, a p53 derived peptide and/or a p53 activating peptide.

Abstract: The present invention relates to compositions useful in inhibiting Bcl-XL or MCL-1 and disrupting p53-MDM2 and p53-MDMX interactions, and methods of using those compositions for treating a subject for conditions responsive to increasing p53 mediated activity or promoting p53 independent apoptosis, such as treating cancer. In some aspects, the compositions of this invention relate to fusion polypeptides comprising a human serum polypeptide and a p53-peptide, which can be, in some aspects, a p53 derived peptide and/or a p53 activating peptide.

Abstract: The present invention relates to compositions useful in inhibiting Bcl-XL or MCL-1 and disrupting p53-MDM2 and p53-MDMX interactions, and methods of using those compositions for treating a subject for conditions responsive to increasing p53 mediated activity or promoting p53 independent apoptosis, such as treating cancer. In some aspects, the compositions of this invention relate to fusion polypeptides comprising a human serum polypeptide and a p53-peptide, which can be, in some aspects, a p53 derived peptide and/or a p53 activating peptide.

Abstract: A localization method and system, including determining phases of a plurality of response signals at a plurality of frequencies received from a radio frequency identification (RFID) tag in response to interrogation signals by a reader at the plurality of frequencies; calculating a first distance estimate of a distance between the RFID tag and the reader based on a signal strength measured from a first response signal of the plurality of response signals; based on the phases and the first distance estimate, calculating a phase slope; and determining a second distance estimate of the distance based upon the phase slope.

Abstract: A localization method and system, including determining at least two phases associated with at least two response signals transmitted by a radio frequency identification (RFID) tag at different frequencies in response to a plurality of interrogation signals transmitted by a reader; determining a first distance estimate of a distance between the RFID tag and the reader based on a signal strength measured from a first response signal of the at least two response signals; based upon the first distance estimate, generating a set of phase data points that follows a substantially periodic function over a range of frequencies; and determining a second distance estimate of the distance based upon the at least two phases and the periodic function.

Abstract: A localization method and system, including calculating a first distance estimate of a distance between a radio frequency identification (RFID) tag and a reader based on information associated with at least one of a plurality of response signals received from the RFID tag in response to interrogation signals by the reader at a plurality frequencies, measuring a signal strength of each of the received plurality of response signals to create a received signal strength indicator (RSSI) signature, predicting an error in the first distance estimate using the RSSI signature, and determining a final distance estimate of the distance by modifying the first distance estimate based on the predicted error.